2',5'-Oligoadenylate [2',5'-oligo(A)J was separated from 14C-labeled nucleosides produced in the 2',5'-oligo(A) synthetase assay by using 100-,ul columns of Dowex 1. No detectable nucleoside remained on the column after elution with 20 column volumes of water, whereas less than 1% of oligonucleotides were eluted from the column. At least 99% of oligonucleotides were eluted from the column with 1 M NaCl, pH 2. The major product had properties consistent with 2',5'-oligo(A). Exposure to alpha-1 bovine interferon (IFN) caused an increase in cellular 2',5'-oligo(A) synthetase activity which was proportional to the concentration of IFN in the medium up to 104 U of IFN per mi and then leveled off at about 15 x control activity. Under the assay conditions used, 2',5'-oligo(A) synthetase activity was directly proportional to the amount of cell extract over a 10-fold range. Cattle inoculated with IBR/BVD/PI-3 modified live virus vaccine showed an increase in 2',5'-oligo(A) synthetase activity in peripheral blood mononuclear leukocytes which persisted for at least 3 days postvaccination. Intramuscular injection of cattle with IFN caused a similar increase in 2',5'-oligo(A) synthetase activity. Changes in 2',5'-oligo(A) synthetase activity should be of value in (i) assessing the response of cattle to experimental viral infections or inoculations with viral vaccines or IFN or (ii) indicating a possible viral etiology in disease.
Interferons (IFNs), which are proteins produced and secreted by virus-infected cells, can cause the establishment of an antiviral state in uninfected cells (1) . Because IFN is formed primarily in response to viral infection, its detection in the body can be a useful diagnostic aid in viral diseases. However, the formation of IFN in cells is a short-term process (43) and its clearance from the blood is rapid (9) , making direct measurement of IFN in serum difficult. Consequently, the sera of a large proportion of humans or domestic animals with viral infections may not contain detectable IFN. All three types of IFN (cx, P, and -y) have the capacity to induce the enzyme 2',5'-oligoadenylate [2',5'-oligo(A)] synthetase, which was discovered by Kerr et al. (19) and which is important in the development of an antiviral state in cells (33) . The enzyme 2',5'-oligo(A) synthetase is considered a reliable marker of IFN action in vitro (8, 10, 13, 14, 18, 19, 32, 35, 45) and in vivo (4, 17, 21, 30, 31, 34, 38, 39) . Schattner et al. (38) have shown that elevation of the enzyme level in the peripheral blood mononuclear leukocytes (PBML) increases early in viral infection and remains elevated for a prolonged time. It has been shown that 2',5'-oligo(A) synthetase activity is increased in PBML during virus infection (2, 4, 7, 20, 22, 37, 38) or treatment with IFN (20, 23, 26) and that the increased activity persists for at least 24 h after administration of IFN (26) . Activity of 2',5'-oligo(A) synthetase has therefore been measured to determine whether humans and other animals have been infected with virus or are responding to IFN (4, 7, 12, 23, 25, 26, 37, 40, 44 Cells were sedimented at 300 x g for 3 min, suspended in an Eppendorf microtest tube in 10 to 100 of PBS per cm2 of monolayer, and resedimented at 300 x g for 3 min. Cells were lysed by suspension in buffer containing the detergent Nonidet P-40, as described by Schattner et al. (38) , and standing at 4°C for 30 min. After centrifugation at 12,000 X g for 5 min, the CE was removed and used immediately for the enzyme assay or kept frozen at -10°C.
Bovine PBML were collected from 2 ml of blood as described by Schattner et al. (38) , except that centrifugation on the Ficoll-Hypaque cushion was at 800 x g for 30 min. CE was prepared as described above at a concentration of 107 cells per ml.
Activity of 2',5'-oligo(A) synthetase. Assay conditions were as described by Schattner et al. (38) height. The column was eluded with 2 ml of water, and the eluent was collected and counted as a single fraction in 15 ml of Scintiverse (Fisher Scientific Co., Pittsburgh, Pa.). The column was then eluded with 2 ml of 0.01 M HCI-i M NaCI, which was collected and counted as described above.
Oligonucleotide digestion. Enzyme digestions were done under the conditions described by Brownlee (3) for SVPD and by Rose (36) for Pi nuclease.
Analytical procedures. Cells were counted by using a hemacytometer. Dinucleoside monophosphates and nucleosides were measured by A,57 at pH 2.
RESULTS
Chromatography on Dowex 1. ApA and adenosine were dissolved separately in medium used for assay of 2',5'-oligo(A) synthetase (38) to give concentrations of 10 and 2.5 mM, respectively. ApA (10 pi) and adenosine (10 pl) were applied separately to 100-pLi columns of Dowex 1. Each column was eluded with 2 ml of water followed by 2 ml of 0.01 M HCI-i M NaCi. Effect of IFN on 2',5'-oligo(A) synthetase activity in MDBK cells. Assay vessels were prepared by using CE from monolayers of MDBK cells not exposed to IFN and MDBK cells exposed to 1(5 U of IFN per ml of medium. Radioactivity of contents of assay vessels was measured directly or the contents were subjected to chromatography on Dowex 1, and the radioactivity of water-and HCI-NaCl-eluted fractions was measured. Detectable radioactivity retained on the columns was less than 0.1% of that applied (15 pCi). Relationship between 2',5'-oligo(A) synthesis and the amount of CE. MDBK cells were exposed to IFN at a concentration of 2 x 105 U/ml of culture medium. The amount of 2',5'-oligo(A) produced under the conditions of the assay was proportional to the amount of CE added, up to an incorporation rate of 500 pmol/h (Fig. 2) CE was reduced at higher rates of incorporation. In four different experiments, the slope of the line relating the amount of CE and synthesis of 2',5'-oligo(A) was linear below levels of incorporation of 30 to 35%. Correlation coefficients were 0.985 to 0.999. The slope of the line obtained by using CE prepared from MDBK cells not exposed to IFN was about 10% of that obtained by using CE from cells exposed to IFN (Fig. 2). 2',5'-Oligo(A) synthetase levels in PBML of cattle inoculated with modified live virus vaccine or IFN. Two animals were injected intravenously with a commercial IBR/BVD/PI-3 modified live virus vaccine; two animals served as controls. Samples of blood were withdrawn into heparinized tubes from both animals 24 h before the injection of vaccine, at the time of injection, and at 24-h intervals after injection for measurement of 2',5'-oligo(A) synthetase. Blood (2 ml) was mixed with 2 ml of PBS, layered on a 3-ml cushion of Ficoll-Hypaque, and centrifuged at 800 x g for 30 min at room temperature. Cells at the interface were collected, washed twice with 5-ml portions of PBS, and sedimented each time by centrifugation at 500 x g for 5 min. The cell pellet was suspended in 100 pi of PBS. A 10-pul portion of the suspension was used for counting cells. The remaining cells were pelleted as above and Iysed in 200 pul oflysis buffer (38) .
Assays for 2',5'-oligo(A) synthetase were done as described above. Results are shown in Fig. 3 . Standard deviations for paired samples are shown for all samples except for the 24-h vaccinated group; the second sample for that group was lost during laboratory preparation of CE.
Two animals were injected intramuscularly with 106 U of IFN per kg of body weight. One animal served as a control. CE was prepared from leukocytes, as described above, from blood which was withdrawn at 0, 24, 48, and 96 h after injection. Results are shown in Fig. 4 separates oligonucleotides from nucleosides produced by the phosphatase treatment of ATP and hence permits the use of '4C-labeled nucleotide precursors of oligo(A). Chromatography on alumina (24) , which is used extensively in the 2',5'-oligo(A) synthetase assay, separates 32P released by the phosphatase treatment from the phosphatase-resistant cores of oligo(A)s. Dowex 1 retained no detectable nucleosides and passed less than 1% of dinucleotides with water as the eluent. Less than 1% of radioactivity applied to columns during regular assay was retained after elution with water and HCl-NaCl, pH 2. Under the conditions used in these experiments, Dowex 1 effectively separated nucleosides from oligonucleotides. Chromatographic properties of larger oligonucleotides were not examined because they bind more strongly than ApA to Dowex 1 and are eluted by 0.01 M HCl-1 mM NaCl (29) .
Exposure of MDBK cells in tissue culture to 105 U of IFN per ml of medium increased the level of 2',5'-oligo(A) synthetase about 20-fold over the level in unexposed cells. This increase is comparable to that described for HeLa cells (6, 15) and for Georgia bovine kidney cells (28) .
The retention of the AP-resistant material from the assay on Dowex 1 columns combined with its susceptibility to degradation by SVPD and its resistance to degradation by Pi nuclease are consistent with a reaction product of 2',5'-oligo(A) (16, 19) . When similarly tested on 3',5'-poly(A), AP alone converted no measurable amount to nucleosides, whereas AP combined with either SVPD or Pi nuclease converted most of it to nucleosides, thus demonstrating that the enzyme preparations were active on 3',5'-linked polymers.
Cell extracts prepared from bovine kidney cells exposed to different concentrations of IFN (2 to 2 x 107 U/ml) contained different amounts of 2',5'-oligo(A) synthetase activity, exhibiting a rough proportionality between concentration of IFN and amount of 2',5'-oligo(A) synthetase activity up to about 2 x 104 U of IFN per ml of medium. These results are consistent with those of Minks et al. (27) and Vanden Broecke (41) , except that the proportionality between concentration of IFN and amount of 2',5'-oligo(A) synthetase appeared to continue to a higher concentration of IFN (2 x 104 U/ml in this work, compared with 1 x 102 to 1 x 103 in the cited works, respectively). No attempt has been made to determine the cause for the differences; they could, however, be caused by the different cell lines that were used. The proportionality between the amount of cell extract used in assays and the amount of 2',5-oligo(A) synthesized demonstrates that enzyme activity can be comparably measured over a severalfold range of enzyme concentrations.
The level of 2',5'-oligo(A) synthetase has been shown to rise significantly in PBML and granulocytes of animals infected with viruses (38) or injected with IFN (42) and in people suffering from viral, bacterial, or autoimmune diseases (4, 7, 22, 25, 44) or receiving IFN therapy (22, 23, 25, 26, 39 ). An assay of 2',5'-oligo(A) synthetase has been suggested for use in assessing the state of disease and recovery of patients suffering from viral or bacterial infections (4, 7, 44) ; for confirming or excluding a possible viral etiology in acute diseases for which alternative nonviral or noninfectious diseases could be considered (7, 37, 38, 44) ; for indicating a possible viral or autoimmune etiology in diseases of obscure pathogenesis (37) ; for monitoring response to IFN therapy (22, 25, 26, 37) ; and as an aid in determining which patients are likely to respond to IFN therapy (22) . In addition, 2',5'-oligo(A) synthetase assays should be of value in assessing prophylactic use of IFN. We are especially interested in the 2',5'-oligo(A) synthetase system for experimental evaluation of IFN for prophylaxis against bovine respiratory diseases and for early and rapid detection of possible viral infections of cattle. Although the 2',5'-oligo(A) synthetase system is not specific for virus diseases, the relative magnitude of the response to virus infection (7, 11, 37) and the rapid determination of results (less than 24 h), combined with history and clinical signs, should make this a useful diagnostic aid (4, 7, 37, 38) .
PBML of calves inoculated with a modified live virus vaccine showed an increase in 2',5'-oligo(A) synthetase which persisted for at least 3 to 4 days. These results are consistent with those reported by others (37, 38, 42) . Analysis of variance for combined data for postinoculation days 1, 2, and 3 showed that the difference between control and inoculated animals was highly significant (P < 0.01). The average increase in 2',5'-oligo(A) synthetase activity in PBML of calves inoculated with modified live virus vaccine was threefold.
Calves injected with IFN showed an average 1.6-fold increase in PBML 2',5'-oligo(A) synthetase activity over the control calf. Although the difference between the control and experimental calves on a given day may not appear to be significant, analysis of variance for combined data for postinoculation days 1, 2, and 3 showed a significant difference (P < 0.05). Injection with larger amounts of IFN may have increased the degree of response; the amount chosen, however, was selected because it corresponds to the dosage currently suggested for clinical applications in cattle. Furthermore, this dose rate is comparable to dose rates that have been shown by Merritt et al. (25) to induce 2.3-to 5.7-fold increases in 2',5'-oligo(A) synthetase activity in PBML of human subjects. Observations similar to those reported herein have been reported for virus-infected mice (38, 39) , and human patients with virus infections (4, 7, 22, 37) or subjected to treatment with IFN (23, 26) . All animals in the IFN experiment evidenced somewhat higher 2',5'-oligo(A) synthetase levels than did those in the vaccine experiment. On the basis of our experience, we believe that two factors may have contributed to the difference. (i) The IFN experiment was done during a period of very hot weather, with daily temperatures above 39°C, which caused stress to the animals. (ii) Animals in the IFN experiment may have been more distressed by handling. Glucocorticoids, which are produced during stress, have been shown to affect IFNinduced enzymes (5) .
This study suggests that the 2',5'-oligo(A) synthetase assay may be useful in confirming or excluding a possible viral etiology in acute diseases and in evaluating response of cattle to prophylactic use of interferon or vaccines as well as to viral challenge.
